We use cookies for a better user experience. Read our Privacy Policy

I Agree

Hantaan Virus Diagnostics Market

Hantaan Virus Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Hantaan Virus Diagnostics: Introduction

  • Hantaan is negative-sense RNA virus that belongs to the Bunyaviridae family. It attacks wild and laboratory rodents. Hantaan virus is common in wild rodents and known to be zoonotic. In humans, the virus is transmitted through contact with rodents’ urine, dropping, or saliva or breathing in same contaminated air. This process is known as airborne transmission. However, the virus is not known to be transferred from human to human.
  • There is no treatment available the Hantaan virus. However, various diagnostic procedures are available to identify infected patients. Hantavirus pulmonary syndrome (HPS) is commonly found in the U.S. and hemorrhagic fever with renal syndrome (HFRS9) has been observed in countries in Europe and Asia. HFRS often leads to low blood pressure and kidney failure, while HPS results in breathlessness and lung illness.

 Key Drivers of Global Hantaan Virus Diagnostics Market

  • High prevalence of the Hantaan virus across the globe is a major factor boosting the global Hantaan virus diagnostics market. Hantaan virus causes HPS, which results in hemorrhagic fever. The major hantavirus responsible for HPS is Sin Nombre virus in the U.S. and is associated with other chronic conditions such as respiratory failure, cardiogenic shock, and pulmonary edema. According to a journal published by NCBI (National Center for Biotechnology Information), Hantaan virus affects around 30,000 humans every year, with no treatment available for this infection.
  • Innovative technologies, such as RT-PCR and next-generation sequencing, provide a comparatively less expensive diagnosis, prognosis, and therapy selection for patients throughout their treatment plan. These technologies help physicians frame appropriate therapeutic regimes for patients suffering from the HTNV (Hantaan orthohantavirus) diseases. Rise in demand for point-of-care services is likely to drive the global Hantaan virus diagnostics market. It also provides quick and accurate results compared to traditional methods. SYBR-Green I-based reverse transcription-quantitative PCR is a simpler and technologically advanced process available for the diagnosis of the Hantaan virus.
  • Awareness and faster adoption rate of diagnostic techniques is higher in developed countries, such as the U.S. and Europe compared to developing countries. However, the adoption rate is low in emerging markets in Asia and Latin America due to underdiagnoses and lack of expertise. Rise in disposable income is also associated with the economic development in developing regions.
  • Unfavorable reimbursement policies act as a major restraint for the global Hantaan virus diagnostics market. Insurance companies refrain from reimbursing HTNV diagnostic tests due to lack of an appropriate coding system. However, these policies are not applied uniformly and vary with different payers in the region. For successful approval of diagnostic tests, a company has to go through a major obstacle of screening and evaluation by the health care regulatory agency of the country. In developing countries, strict regulations is a hurdle for the approval of the innovative Hantaan virus diagnostic tests.

Molecular Testing to be Highly Promising Segment

  • In terms of test type, the global Hantaan virus diagnostics market can be classified into serology, molecular tests, and viral antigen detection tests
  • Molecular testing is the most innovative and rapid test adopted for the diagnosis of the Hantaan virus. Molecular testing offers high specificity and sensitivity and is a widely preferred innovative technology.
  • Polymerase chain reaction (PCR) allows detection of other Hantaviruses, such as Puumala virus or Dobrava virus, which could effectively cause hepatopulmonary syndrome or hemorrhagic renal fever. Real time PCR (RT-PCR) is an advanced technology, which allows quantitative viral antigen detection by using the S segment of the viral genome. Technological advancements and clinical studies support the adoption of the PCR technique for Hantaan virus diagnosis globally.

Hantavirus Pulmonary Syndrome to be Highly Promising Segment

  • Based on application, the global Hantaan virus diagnostics market can be categorized into Hantavirus pulmonary syndrome (HVPS), hemorrhagic fever renal syndrome (HFRS), and others
  • The Hantavirus pulmonary syndrome (HVPS) segment accounted for prominent share of the global Hantaan virus diagnostics market in 2020 due to increase in number of patients suffering from Hantavirus pulmonary syndrome (HVPS).

Hospitals to be Most Lucrative Segment

  • In terms of end-user, the global Hantaan virus diagnostics market can be divided into hospitals, diagnostic laboratories, and others. Hospitals was the largest segment in terms of revenue in 2020 and is anticipated to witness strong growth during the forecast period.
  • Most of the Hantaan virus patients visit hospitals for diagnosis and treatment. This is likely to drive the hospitals segment during the forecast period.

Asia Pacific to Dominate Global Hantaan Virus Diagnostics Market

  • In terms of region, the global Hantaan virus diagnostics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • Asia Pacific is considered the most affected region by Hantavirus infection in the world and is likely to be a lucrative market in the near future. Rise in prevalence of Hantaan virus, especially in China, South Korea, and other developing countries, is a major factor fueling the demand for diagnostics test. Countries in Asia are majorly affected by HFRS caused by the Hantaan virus. According to a study published in NCBI, HFRS has become an emerging threat for the public.
  • In China, major HFRS cases caused by the HTNV strain accounted for 90% of the total global cases. Technological advancements and adoption & awareness about screening methods are likely to drive the Hantaan virus diagnostics market in Asia Pacific during the forecast period. Southeast Asia is considered vulnerable to the Hantavirus. Government policies and adoption of rapid diagnostic tests are likely to augment the market in the region.

Key Players Operating in Global Market

The global Hantaan virus diagnostics market was highly fragmented in 2020. Key players operating in the global market are:

  • Creative Diagnostics
  • R-Biopharm AG
  • Abbott
  • Genome Diagnostics Pvt. Ltd.
  • Euroimmun AG ( PerkinElmer company)
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific Inc.
  •  Other prominent players

Global Hantaan Virus Diagnostics Market: Research Scope

Global Hantaan Virus Diagnostics Market, by Test Type

  • Serology
    • Enzyme Linked Immunosorbent Assay (ELISA)
    • Immunofluorescence Assay (IFA)
    • Immunoblot & Neutralization Tests
  • Molecular Tests
    • PCR (Polymerase Chain Reaction) Test
    • Others
  • Viral Antigen Detection Tests
    • Immunohistochemistry
    • Others

Global Hantaan Virus Diagnostics Market, by Application

  • Hantavirus Pulmonary Syndrome (HVPS)
  • Hemorrhagic Fever Renal Syndrome (HFRS)
  • Others

Global Hantaan Virus Diagnostics Market, by End-user

  • Hospitals
  • Diagnostic Laboratories
  • Others

Global Hantaan Virus Diagnostics Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa
Hantaan Virus Diagnostics Market

Interested in this report?
Get a FREE Brochure now!

Request Brochure

*Get Brochure (PDF) sent to your email within minutes


Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.


Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved